Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein.

Marta J Gonzalez-Hernandez, James D Cavalcoli, Maureen A Sartor, Rafael Contreras-Galindo, Fan Meng, Manhong Dai, Derek Dube, Anjan K Saha, Scott D Gitlin, Gilbert S Omenn, Mark H Kaplan, David M Markovitz
Author Information
  1. Marta J Gonzalez-Hernandez: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA Program in Immunology, University of Michigan, Ann Arbor, Michigan, USA.
  2. James D Cavalcoli: Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.
  3. Maureen A Sartor: Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
  4. Rafael Contreras-Galindo: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  5. Fan Meng: Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA Molecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan, USA.
  6. Manhong Dai: Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA Molecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, Michigan, USA.
  7. Derek Dube: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  8. Anjan K Saha: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  9. Scott D Gitlin: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA Department of Veterans Affairs, University of Michigan, Ann Arbor, Michigan, USA.
  10. Gilbert S Omenn: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA School of Public Health, University of Michigan, Ann Arbor, Michigan, USA National Center for Integrative Biomedical Informatics, University of Michigan, Ann Arbor, Michigan, USA Department of Human Genetics, University of Michigan, Ann Arbor, Michigan, USA.
  11. Mark H Kaplan: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  12. David M Markovitz: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA Program in Immunology, University of Michigan, Ann Arbor, Michigan, USA Program in Cancer Biology, University of Michigan, Ann Arbor, Michigan, USA Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, Michigan, USA dmarkov@umich.edu.

Abstract

Approximately 8% of the human genome is made up of endogenous retroviral sequences. As the HIV-1 Tat protein activates the overall expression of the human endogenous retrovirus type K (HERV-K) (HML-2), we used next-generation sequencing to determine which of the 91 currently annotated HERV-K (HML-2) proviruses are regulated by Tat. Transcriptome sequencing of total RNA isolated from Tat- and vehicle-treated peripheral blood lymphocytes from a healthy donor showed that Tat significantly activates expression of 26 unique HERV-K (HML-2) proviruses, silences 12, and does not significantly alter the expression of the remaining proviruses. Quantitative reverse transcription-PCR validation of the sequencing data was performed on Tat-treated PBLs of seven donors using provirus-specific primers and corroborated the results with a substantial degree of quantitative similarity.
IMPORTANCE: The expression of HERV-K (HML-2) is tightly regulated but becomes markedly increased following infection with HIV-1, in part due to the HIV-1 Tat protein. The findings reported here demonstrate the complexity of the genome-wide regulation of HERV-K (HML-2) expression by Tat. This work also demonstrates that although HERV-K (HML-2) proviruses in the human genome are highly similar in terms of DNA sequence, modulation of the expression of specific proviruses in a given biological situation can be ascertained using next-generation sequencing and bioinformatics analysis.

References

  1. AIDS. 1994 Oct;8(10):1504-6 [PMID: 7818827]
  2. Genomics. 2004 Dec;84(6):982-90 [PMID: 15533715]
  3. Nat Protoc. 2012 Mar 01;7(3):562-78 [PMID: 22383036]
  4. Nucleic Acids Res. 2003 Jul 1;31(13):3651-3 [PMID: 12824386]
  5. J Clin Invest. 2012 Dec;122(12):4473-89 [PMID: 23143309]
  6. Nat Methods. 2008 Jul;5(7):621-8 [PMID: 18516045]
  7. J Virol. 1999 Mar;73(3):2365-75 [PMID: 9971820]
  8. Melanoma Res. 2010 Oct;20(5):435-40 [PMID: 20539243]
  9. Genome Res. 2006 Dec;16(12):1548-56 [PMID: 17077319]
  10. J Virol. 1987 Jun;61(6):2059-62 [PMID: 2883329]
  11. J Virol Methods. 2006 Sep;136(1-2):51-7 [PMID: 16678919]
  12. Annu Rev Genet. 2008;42:709-32 [PMID: 18694346]
  13. Nucleic Acids Res. 1991 Apr 11;19(7):1513-20 [PMID: 2027759]
  14. J Clin Virol. 2009 Sep;46(1):15-9 [PMID: 19505847]
  15. J Biol Chem. 2010 Mar 19;285(12):8646-55 [PMID: 20080975]
  16. BMC Genomics. 2008 Jul 29;9:354 [PMID: 18664271]
  17. Virology. 2007 Feb 5;358(1):39-47 [PMID: 16997346]
  18. J Immunol. 2006 Aug 15;177(4):2056-60 [PMID: 16887963]
  19. Leukemia. 2013 Jul;27(7):1469-78 [PMID: 23307033]
  20. Genomics. 2005 Sep;86(3):337-41 [PMID: 16024218]
  21. J Immunol. 2002 Jan 1;168(1):95-101 [PMID: 11751951]
  22. Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14572-9 [PMID: 15310846]
  23. Biochim Biophys Acta. 2011 Feb;1812(2):162-76 [PMID: 20696240]
  24. Mol Biol Evol. 2009 Nov;26(11):2617-26 [PMID: 19666991]
  25. J Rheumatol. 2006 Jan;33(1):16-23 [PMID: 16395745]
  26. Blood. 1993 May 1;81(9):2369-74 [PMID: 7683217]
  27. Nat Genet. 1999 Mar;21(3):257-8 [PMID: 10080172]
  28. Proteomics. 2006 Apr;6 Suppl 1:S63-73 [PMID: 16526095]
  29. N Biotechnol. 2013 Mar 25;30(3):314-8 [PMID: 23201072]
  30. Mol Cell Biol. 1998 Jan;18(1):58-68 [PMID: 9418853]
  31. Cancer Res. 2005 May 15;65(10):4172-80 [PMID: 15899808]
  32. Bioinformatics. 2002 Feb;18(2):333-4 [PMID: 11847087]
  33. J Virol. 2004 Oct;78(19):10310-9 [PMID: 15367597]
  34. J Gen Virol. 2010 Jun;91(Pt 6):1494-502 [PMID: 20147518]
  35. Stat Med. 1998 Apr 30;17(8):873-90 [PMID: 9595617]
  36. J Virol. 2008 Oct;82(19):9329-36 [PMID: 18632860]
  37. Virus Genes. 2003 May;26(3):291-315 [PMID: 12876457]
  38. Oncogene. 2005 Apr 28;24(19):3223-8 [PMID: 15735668]
  39. Plant Mol Biol. 1998 Feb;36(3):365-76 [PMID: 9484477]
  40. Gene Expr. 1992;2(4):391-407 [PMID: 1282057]
  41. Annu Rev Genomics Hum Genet. 2006;7:149-73 [PMID: 16722807]
  42. AIDS Res Hum Retroviruses. 2006 Oct;22(10):979-84 [PMID: 17067267]
  43. Intern Med. 2001 Feb;40(2):80-6 [PMID: 11300167]
  44. Virus Res. 2002 Jun;86(1-2):93-100 [PMID: 12076833]
  45. Oncogene. 2000 Sep 7;19(38):4328-36 [PMID: 10980608]
  46. Mol Pathol. 2003 Feb;56(1):11-8 [PMID: 12560456]
  47. J Mol Evol. 2005 Nov;61(5):706-15 [PMID: 16211423]
  48. Retrovirology. 2012 Jan 16;9:6 [PMID: 22248111]
  49. Nature. 2012 Sep 6;489(7414):57-74 [PMID: 22955616]
  50. J Acquir Immune Defic Syndr (1988). 1992;5(11):1142-7 [PMID: 1403646]
  51. J Virol. 2007 Jun;81(11):5607-16 [PMID: 17360752]
  52. Nat Rev Genet. 2012 Mar 16;13(4):283-96 [PMID: 22421730]
  53. Clin Immunol. 1999 Oct;93(1):75-80 [PMID: 10497013]
  54. Brain Res Mol Brain Res. 2005 Feb 18;133(2):299-306 [PMID: 15710247]
  55. AIDS Res Hum Retroviruses. 2007 Sep;23(9):1083-6 [PMID: 17919102]
  56. Genome Res. 2013 Sep;23(9):1505-13 [PMID: 23657884]
  57. Bioinformatics. 2009 May 1;25(9):1105-11 [PMID: 19289445]
  58. Virus Res. 2001 Nov 5;79(1-2):39-45 [PMID: 11551644]
  59. Pigment Cell Melanoma Res. 2013 May;26(3):426-8 [PMID: 23311654]
  60. J Virol. 2005 Dec;79(24):15573-7 [PMID: 16306628]
  61. J Invest Dermatol. 1999 Oct;113(4):587-94 [PMID: 10504445]
  62. J Virol. 2012 Aug;86(15):7790-805 [PMID: 22593154]
  63. Retrovirology. 2011 Nov 08;8:90 [PMID: 22067224]
  64. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13 Suppl 1:S261-7 [PMID: 8797733]
  65. J Gen Virol. 2008 Feb;89(Pt 2):567-572 [PMID: 18198388]
  66. Clin Cancer Res. 2002 Jun;8(6):1800-7 [PMID: 12060620]
  67. Curr Biol. 1999 Aug 26;9(16):861-8 [PMID: 10469592]
  68. Tohoku J Exp Med. 1994 May;173(1):105-14 [PMID: 7809902]
  69. Proc Natl Acad Sci U S A. 1996 May 28;93(11):5177-84 [PMID: 8643549]
  70. J Virol. 2012 Jan;86(1):262-76 [PMID: 22031938]
  71. Melanoma Res. 2006 Jun;16(3):223-34 [PMID: 16718269]
  72. AIDS Res Hum Retroviruses. 2007 Jan;23(1):116-22 [PMID: 17263641]
  73. Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4894-9 [PMID: 15044706]
  74. J Gen Virol. 1992 Sep;73 ( Pt 9):2463-6 [PMID: 1402820]
  75. Clin Vaccine Immunol. 2012 Feb;19(2):288-92 [PMID: 22205657]
  76. J Clin Virol. 2009 Sep;46(1):47-8 [PMID: 19505843]
  77. Curr Biol. 2001 Oct 2;11(19):1531-5 [PMID: 11591322]
  78. J Virol. 2009 Mar;83(6):2429-35 [PMID: 19116259]
  79. AIDS Res Hum Retroviruses. 1992 Dec;8(12):1991-8 [PMID: 1493049]
  80. Bioinformatics. 2010 Mar 15;26(6):841-2 [PMID: 20110278]
  81. J Virol. 2005 Jan;79(1):341-52 [PMID: 15596828]
  82. Clin Exp Immunol. 2010 Jun;160(3):340-7 [PMID: 20345981]
  83. Curr Opin Rheumatol. 1998 Jul;10(4):347-54 [PMID: 9725097]
  84. Nature. 2012 Sep 6;489(7414):109-13 [PMID: 22955621]
  85. J Gen Virol. 2001 Mar;82(Pt 3):591-596 [PMID: 11172100]
  86. Viruses. 2011 Nov;3(11):2146-59 [PMID: 22163338]

Grants

  1. R01 AI062248/NIAID NIH HHS
  2. U54DA021519/NIDA NIH HHS
  3. F31 CA150523/NCI NIH HHS
  4. T32 GM007863/NIGMS NIH HHS
  5. R01AI062248/NIAID NIH HHS
  6. P30 ES017885/NIEHS NIH HHS
  7. U54 DA021519/NIDA NIH HHS
  8. 5T32AI007528/NIAID NIH HHS
  9. R01 CA144043/NCI NIH HHS
  10. 1F31CA150523/NCI NIH HHS
  11. T32 AI007528/NIAID NIH HHS
  12. UL1RR24986/NCRR NIH HHS
  13. RM-08-029/RMOD NIH HHS
  14. 3R01CA144043-03S1/NCI NIH HHS
  15. R01CA144043/NCI NIH HHS
  16. UL1 RR024986/NCRR NIH HHS
  17. P30U54ES017885/NIEHS NIH HHS

MeSH Term

Cells, Cultured
Endogenous Retroviruses
Gene Products, tat
Genome, Human
HIV Infections
HIV-1
High-Throughput Nucleotide Sequencing
Humans
Lymphocytes
Proviruses
RNA, Viral
Transcriptome
Viral Proteins

Chemicals

Gene Products, tat
RNA, Viral
Viral Proteins

Word Cloud

Created with Highcharts 10.0.0HML-2TatexpressionHERV-KproviruseshumanHIV-1sequencingendogenousproteingenomeactivatesretrovirusKnext-generationregulatedsignificantlyusingApproximately8%maderetroviralsequencesoveralltypeuseddetermine91currentlyannotatedTranscriptometotalRNAisolatedTat-vehicle-treatedperipheralbloodlymphocyteshealthydonorshowed26uniquesilences12alterremainingQuantitativereversetranscription-PCRvalidationdataperformedTat-treatedPBLssevendonorsprovirus-specificprimerscorroboratedresultssubstantialdegreequantitativesimilarityIMPORTANCE:tightlybecomesmarkedlyincreasedfollowinginfectionpartduefindingsreporteddemonstratecomplexitygenome-wideregulationworkalsodemonstratesalthoughhighlysimilartermsDNAsequencemodulationspecificgivenbiologicalsituationcanascertainedbioinformaticsanalysisRegulationtranscriptome

Similar Articles

Cited By